医学部 感染症科
基本情報
研究キーワード
5研究分野
1経歴
12-
2022年7月 - 現在
-
2022年7月
-
2015年4月 - 2022年6月
-
2013年7月 - 2022年6月
学歴
2-
2012年4月 - 2013年3月
-
1994年4月 - 2000年3月
委員歴
4-
2019年2月 - 現在
-
2018年4月 - 現在
-
2014年1月 - 2017年12月
受賞
8-
2019年2月
-
2012年10月
論文
98-
Sexually Transmitted Diseases 2025年2月25日 査読有り最終著者責任著者
-
Infection Control & Hospital Epidemiology 2025年2月14日 査読有り最終著者責任著者
-
Asia-Pacific journal of public health 10105395241305929-10105395241305929 2024年12月17日 査読有りFew longitudinal studies have examined the impact of the COVID-19 pandemic on personal behaviors. This study investigated changes in four social behaviors among the Japanese public during and after the COVID-19 pandemic, using four-wave longitudinal data (2020-2023) from the Japan COVID-19 and Society Internet Survey (JACSIS). In total, 8622 respondents continuously participated in the surveys. In JACSIS 2023, the percentage of individuals who always refrained from specific actions decreased compared with 2020: traveling (71.0%-30.9%), non-essential and non-urgent outings (60.6%-24.5%), crowded spaces (62.6%-28.0%), and eating out (49.5%-21.6%). Mixed-effects logistic regression analysis indicated that essential health care workers displayed more cautious behavior than other workers, and respondents were less likely to refrain from these actions in JACSIS 2023 compared with 2020. Understanding behavioral changes is crucial to evaluating the efficacy of COVID-19 prevention measures and improving future pandemic response strategies.
-
Vaccines 12(11) 2024年11月8日 査読有りBackground/Objectives: Japan's COVID-19 vaccination campaign achieved high coverage by 2022, yet limited national-level data has hindered evaluations of vaccine effectiveness. This study analyzed the impact of vaccines on infection outcomes while considering socioeconomic and behavioral factors in the Japanese population. Methods: A total of 19,482 individuals aged 16-81 years, who participated in both the 2021 (baseline) and 2022 (follow-up) waves of an Internet-based survey, were analyzed. Vaccine intake during the follow-up period (0/1/2+ doses) served as the exposure, while outcomes included COVID-19 diagnosis, hospitalization, and receipt of oxygenation/ventilation. Adjusted prevalence ratios (APRs) were calculated using Poisson regression models, controlling for baseline characteristics such as vaccination status, infection history, underlying medical conditions, socioeconomic factors, and preventive behaviors. Results: Overall, 81.6% of respondents received at least 1 dose of COVID-19 vaccine during the follow-up period. Among those without COVID-19 history at baseline (N = 19,182), 10.9% were diagnosed with COVID-19 in the past year, and 6.6% in the past 2 months. Respondents who received 1 or 2+ doses had lower diagnosis rates (APR = 0.76 and 0.43, respectively). For the past 2 months, only those with 2+ doses showed a significant reduction (APR = 0.51). Among 1999 diagnosed cases, those with 1 or 2+ doses showed lower hospitalization and oxygenation/ventilation likelihoods, though these differences were not statistically significant. Conclusions: The results supported the protective effect of COVID-19 vaccines against infection. Continued research is essential to further clarify the complex influence of vaccination, individual characteristics, and preventive behaviors on COVID-19 morbidity at the population level.
-
Journal of public health (Oxford, England) 2024年10月10日 査読有りBACKGROUND: The present study aimed to investigate the association between the duration of anti-coronavirus disease 2019 (COVID-19) public health measures and the quality of life (QOL) and mental health of the Japanese public. METHODS: The present, nationwide, questionnaire-based, cross-sectional study was conducted in September 2021. The cumulative duration in days of anti-COVID-19 public health measures was calculated for each prefecture in the year prior to the survey, and multilevel linear regression analysis was used to determine the association between the duration of these measures and any impairment of QOL or mental health as assessed by the EuroQol 5-dimensions 5-levels (EQ-5D-5L) and the Kessler scale (K6). RESULTS: The study included 28 118 participants from all 47 prefectures. The median duration of public health measures of all prefectures was 179 days. Long-term duration of the measures (181-365 days) was not independently associated with low EQ-5D-5L (P = 0.128) or high K6 (P = 0.179) scores after adjusting for potential confounders (Graphical Abstract). CONCLUSIONS: Prolongation of the measures may not be associated with a deterioration in the QOL or mental health of the Japanese public. Nevertheless, it may be necessary to reconsider long-term public health measures given the potential they may have to cause collateral damage, such as socioeconomic one.
MISC
106-
Intensivist 15(4) 607-615 2023年10月<文献概要>ICUに入室する患者には,背景に免疫不全の病態を有する患者が数多く存在している。免疫不全患者が感染症に罹患した際の予後は一般的に悪い。また,昨今さまざまな免疫抑制剤や抗腫瘍薬が使用可能となり,各薬物投与後に生じる,いくつかの特徴的な感染症が認知されている。一般に免疫不全患者の感染症では,想定される起炎菌,使用すべき抗微生物薬も一般の感染症と異なることがあり,この分野の感染症診療の包括的な教育が必要である。
書籍等出版物
5共同研究・競争的資金等の研究課題
3-
日本学術振興会 科学研究費助成事業 2023年4月 - 2026年3月
-
日本学術振興会 科学研究費助成事業 基盤研究(C) 2019年4月 - 2022年3月
-
日本学術振興会 科学研究費助成事業 基盤研究(C) 2016年4月 - 2020年3月